Search for "free energy" in Full Text gives 191 result(s) in Beilstein Journal of Organic Chemistry.
Beilstein J. Org. Chem. 2011, 7, 744–758, doi:10.3762/bjoc.7.85
Graphical Abstract
Figure 1: Chiral aryl selenium electrophiles 1–3.
Scheme 1: Plausible mechanism of alkene selenenylation.
Figure 2: Plot of log krel values for PhSeCl addition to alkenes versus their corresponding IEs. Point number...
Figure 3: Plot of log krel values for PhSeCl addition to alkenes versus their corresponding HOMOs, analogous ...
Figure 4: Plot of log krel versus HOMO shows data grouped by branching at α position. Data are from Table 3; point n...
Scheme 2: Major products from reactions of 1 and 2 with representative alkenols.
Figure 5: Structure of intermediate complex 9.
Figure 6: Plot of log krel values for PhSCl addition to alkenes versus their IEs. Data are from Table 6.
Beilstein J. Org. Chem. 2011, 7, 622–630, doi:10.3762/bjoc.7.73
Graphical Abstract
Scheme 1: Gold-catalyzed cyclization of 4-allenyl-2-azetidinones for the preparation of bicyclic β-lactams.
Scheme 2: Possible catalytic cycle for the gold-catalyzed cyclization of 4-allenyl-2-azetidinones.
Scheme 3: Gold- and iron-catalyzed chemodivergent cyclization of ene-allenols for the preparation of oxacycli...
Scheme 4: Gold-catalyzed cyclization of hydroxyallenes for the preparation of five-membered oxacyclic β-lacta...
Figure 1: Free energy profile [kcal mol–1] for the transformation of γ-allenol I into the tetrahydrofuran typ...
Scheme 5: Possible catalytic cycle for the gold-catalyzed cyclization of hydroxyallenes.
Scheme 6: Gold-catalyzed cyclization of MOM-protected α-hydroxyallenes for the preparation of five-membered o...
Scheme 7: Gold-catalyzed cyclization of MOM-protected γ-hydroxyallenes for the preparation of seven-membered ...
Scheme 8: Possible catalytic cycle for the gold-catalyzed cyclization of MOM protected γ-allenol derivatives....
Scheme 9: Au(III)-catalyzed heterocyclization reaction of MOM protected γ-allenol derivative 14a.
Scheme 10: Precious metal-catalyzed formation of benzo-fused pyrrolizinones from N-(2-alkynylphenyl)-β-lactams....
Scheme 11: Gold-catalyzed formation of 5,6-dihydro-8H-indolizin-7-ones from N-(pent-2-en-4-ynyl)-β-lactams.
Scheme 12: Gold-catalyzed formation of non-fused tetrahydrofuryl-β-lactam hemiacetals from 2-azetidinone-tethe...
Scheme 13: Gold-catalyzed formation of spiro tetrahydrofuryl-β-lactam hemiacetals from 2-azetidinone-tethered ...
Scheme 14: Gold-catalyzed formation of fused tetrahydrofuryl-β-lactam hemiacetals from 2-azetidinone-tethered ...
Scheme 15: Possible catalytic cycle for the gold-catalyzed cyclization of MOM protected alkynol derivatives.
Scheme 16: Gold/Brønsted acid co-catalyzed formation of bridged β-lactam acetals from 2-azetidinone-tethered a...
Beilstein J. Org. Chem. 2011, 7, 543–552, doi:10.3762/bjoc.7.62
Graphical Abstract
Figure 1: Molecular structures of syn-isobutyl chloroformate (1), syn-isobutyl chlorothioformate (2), phenyl ...
Scheme 1: Stepwise addition–elimination mechanism through a tetrahedral intermediate for solvolysis of chloro...
Scheme 2: Unimolecular solvolytic pathway for the dithioformate esters.
Figure 2: The plot of log (k/k0) for iBuOCOCl (1) against log (k/k0) for PhOCOCl (3).
Figure 3: The plot of log (k/k0) for isobutyl chloroformate (1) against 1.82 NT + 0.53 YCl in eighteen pure a...
Figure 4: The plot of log (k/k0) for isobutyl chlorothioformate (2) against 0.42 NT + 0.73 YCl in 15 pure and...
Beilstein J. Org. Chem. 2011, 7, 525–542, doi:10.3762/bjoc.7.61
Graphical Abstract
Scheme 1: Photochemistry of benzene.
Scheme 2: Three distinct modes of photocycloaddition of arenes to alkenes.
Scheme 3: Mode selectivity with respect of the free enthalpy of the radical ion pair formation.
Scheme 4: Photocycloaddition shows lack of mode selectivity.
Scheme 5: Mechanism of the meta photocycloaddition.
Scheme 6: Evidence of biradiacal involved in meta photocycloaddition by Reedich and Sheridan.
Scheme 7: Regioselectivity with electron withdrawing and electron donating substituents.
Scheme 8: Closure of cyclopropyl ring affords regioisomers.
Scheme 9: Endo versus exo product in the photocycloaddition of pentene to anisole [33].
Scheme 10: Regio- and stereoselectivity in the photocycloaddition of cyclopentene with a protected isoindoline....
Scheme 11: 2,6- and 1,3-addition in intramolecular approach.
Scheme 12: Linear and angularly fused isomers can be obtained upon intramolecular 1,3-addition.
Scheme 13: Synthesis of α-cedrene via diastereoselective meta photocycloaddition.
Scheme 14: Asymmetric meta photocycloaddition introduced by chirality of tether at position 2.
Scheme 15: Enantioselective meta photocycloaddition in β-cyclodextrin cavity.
Scheme 16: Vinylcyclopropane–cyclopentene rearrangement.
Scheme 17: Further diversification possibilities of the meta photocycloaddition product.
Scheme 18: Double [3 + 2] photocycloaddition reaction affording fenestrane.
Scheme 19: Total synthesis of Penifulvin B.
Scheme 20: Towards the total synthesis of Lacifodilactone F.
Scheme 21: Regioselectivity of ortho photocycloaddition in polarized intermediates.
Scheme 22: Exo and endo selectivity in ortho photocycloaddition.
Scheme 23: Ortho photocycloaddition of alkanophenones.
Scheme 24: Photocycloadditions to naphtalenes usually in an [2 + 2] mode [79].
Scheme 25: Ortho photocycloaddition followed by rearrangements.
Scheme 26: Stable [2 + 2] photocycloadducts.
Scheme 27: Ortho photocycloadditions with alkynes.
Scheme 28: Intramolecular ortho photocycloaddition and rearrangement thereof.
Scheme 29: Intramolecular ortho photocycloaddition to access propellanes.
Scheme 30: Para photocycloaddition with allene.
Scheme 31: Photocycloadditions of dianthryls.
Scheme 32: Photocycloaddition of enone with benzene.
Scheme 33: Intramolecular photocycloaddition affording multicyclic compounds via [4 + 2].
Scheme 34: Photocycloaddition described by Sakamoto et al.
Scheme 35: Proposed mechanism by Sakamoto et al.
Scheme 36: Photocycloaddition described by Jones et al.
Scheme 37: Proposed mechanism for the formation of benzoxepine by Jones et al.
Scheme 38: Photocycloaddition observed by Griesbeck et al.
Scheme 39: Mechanism proposed by Griesbeck et al.
Scheme 40: Intramolecular photocycloaddition of allenes to benzaldehydes.
Beilstein J. Org. Chem. 2011, 7, 145–150, doi:10.3762/bjoc.7.20
Graphical Abstract
Figure 1: Four low energy conformations of 4-propylaniline obtained from B3LYP/6-31G* conformational search a...
Figure 2: Plot of the mean calculated error arising from fitting the population distribution of conformers 1a...
Beilstein J. Org. Chem. 2011, 7, 104–110, doi:10.3762/bjoc.7.14
Graphical Abstract
Scheme 1: Synthesis of complex 1a.
Scheme 2: Synthesis of complexes 2 and 3.
Scheme 3: Synthesis of complexes 1b–i.
Figure 1: Naphthyl-group region of 1H,1H-COSY NMR for 1g in CD2Cl2 at −80 °C.
Figure 2: 1H NMR (top) and NOE difference spectrum (bottom) of 1g in CD2Cl2 at −80 °C, saturating the methyli...
Scheme 4: Conformational isomerism in complex 1g.
Figure 3: Olefin and alkylidene-proton region of the 1H NMR (top) and NOE difference spectrum (bottom) of 1e ...
Scheme 5: Conformational isomerism in complex 1e.
Figure 4: Olefin and alkyl group region of the 1H NMR (top) and NOE difference spectrum (bottom) of 1e in CD2...
Beilstein J. Org. Chem. 2011, 7, 40–45, doi:10.3762/bjoc.7.7
Graphical Abstract
Scheme 1: Possible products resulting from the CM of terminal olefins.
Scheme 2: Representation of the reactions investigated.
Figure 1: Reaction profile for the formation of cis- and trans-2-butene.
Beilstein J. Org. Chem. 2011, 7, 13–21, doi:10.3762/bjoc.7.3
Graphical Abstract
Scheme 1: Alkene metathesis mechanism.
Scheme 2: Metathesis possibilities.
Scheme 3: Metathesis with Re-based alumina supported catalysts.
Figure 1: (E/Z) ratio as a function of conversion. a) MeReO3 supported on alumina and b) MeReO3 supported on ...
Scheme 4: Alkene selectivity of metathesis reactions.
Scheme 5: Hybrid organic–inorganic catalyst containing a Ru–NHC unit.
Beilstein J. Org. Chem. 2010, 6, 1043–1055, doi:10.3762/bjoc.6.119
Graphical Abstract
Scheme 1: Synthesis and transformation of nonracemic silyl-protected cyanohydrins.
Figure 1: Highly active metal(salen) complexes for asymmetric cyanohydrin synthesis.
Scheme 2: Synthesis of cyclic carbonates.
Scheme 3: Synthesis of cyanohydrin trimethylsilyl ethers and acetates.
Scheme 4: Equilibrium between bimetallic and monometallic Ti(salen) complexes.
Figure 2: Second-order kinetics plot for the addition of TMSCN to benzaldehyde at 0 °C catalysed by complex 2...
Figure 3: Plot of k2obs against [2], showing that the reactions are first order with respect to the concentratio...
Figure 4: Eyring plot to determine the activation parameters for catalyst 2 in propylene carbonate. The red a...
Figure 5: 51V NMR spectra of complex 2 recorded at 50 °C. a) Spectrum in CDCl3; b) spectrum in CDCl3 with 500...
Figure 6: Structures consistent with the 51V NMR spectra.
Figure 7: Bimetallic aluminium(salen) complex for asymmetric cyanohydrin synthesis.
Figure 8: Rate determining transition states for asymmetric cyanohydrin synthesis: a) when Lewis base catalys...
Figure 9: Hammett correlations with catalyst 2 at 0 °C. Data in red are obtained in dichloromethane [52], whilst ...
Beilstein J. Org. Chem. 2010, 6, 1026–1034, doi:10.3762/bjoc.6.117
Graphical Abstract
Figure 1: Free energy profiles for reactions of substrate S uncatalysed and catalysed by enzyme E, showing ho...
Scheme 1: SN2 methyl transfer from SAM to catechol catalysed by COMT.
Figure 2: Energetic analysis of the compression hypothesis for enzyme-catalysed methyl transfer.
Figure 3: Catalyst design for methyl transfer: (a) the reaction to be catalysed; (b) dipoles favourably align...
Scheme 2: SN2 methyl transfer (a) uncatalysed and (b) within a cryptand cavity.
Figure 4: Free energy analysis of COMT catalysis.
Scheme 3: Formation of glycosyl-enzyme covalent intermediate COV.
Figure 5: Conformational change of the xylose ring from chair (via envelope) with long OYHY…Oring hydrogen bo...
Figure 6: AM1/OPLS potentials of mean force for formation of glycosyl-enzyme covalent intermediate between 4-...
Figure 7: Hydrogen-bond distances HY…Oring (red) and HY…Onuc (blue) to boat conformer of RC, TS and glycosyl-...
Beilstein J. Org. Chem. 2010, 6, No. 74, doi:10.3762/bjoc.6.74
Graphical Abstract
Figure 1: Nematic orientational correlation function G(r) for different values of x (x = 0.01 and 0.25), N = ...
Figure 2: (a) The nematic domain length ξ, (b) the domain dispersion parameter m, and (c) the range parameter...
Figure 3: Degree of biaxiality β2 as a function of x; JLC–NP: −1, −2, and −4; JLC–LC = JLC–NP = 1, N = 80 × 8...
Beilstein J. Org. Chem. 2010, 6, No. 66, doi:10.3762/bjoc.6.66
Graphical Abstract
Figure 1: Structures of monomers 1–7 and chain transfer agent 8 used in the RAFT polymerizations.
Figure 2: a) Second derivative UV–vis spectra [17-19] observed during a full titration of a stock solution of RAFT c...
Figure 3: Isothermal calorimetric binding curves for selected polymer/protein host–guest pairs. a) Typical bi...
Figure 4: Graphical illustration of the potential binding mode on hemoglobin tetramer (represented as electro...
Beilstein J. Org. Chem. 2010, 6, No. 32, doi:10.3762/bjoc.6.32
Graphical Abstract
Figure 1: Biologically important amines and quaternary ammonium salts: histamine (1), dopamine (2) and acetyl...
Figure 2: Crown ether 18-crown-6.
Figure 3: Conformations of 18-crown-6 (4) in solvents of different polarity.
Figure 4: Binding topologies of the ammonium ion depending on the crown ring size.
Figure 5: A “pseudorotaxane” structure consisting of 24-crown-8 and a secondary ammonium ion (5); R = Ph.
Figure 6: Typical examples of azacrown ethers, cryptands and related aza macrocycles.
Figure 7: Binding of ammonium to azacrown ethers and cryptands [111-113].
Figure 8: A 19-crown-6-ether with decalino blocking groups (11) and a thiazole-dibenzo-18-crown-6-ether (12).
Figure 9: 1,3-Bis(6-oxopyridazin-1-yl)propane derivatives 13 and 14 by Campayo et al.
Figure 10: Fluorescent azacrown-PET-sensors based on coumarin.
Figure 11: Two different pyridino-cryptands (17 and 18) compared to a pyridino-crown (19); chiral ammonium ion...
Figure 12: Pyridino-18-crown-6 ligand (21), a similar acridino-18-crown-6 ligand (22) and a structurally relat...
Figure 13: Ciral pyridine-azacrown ether receptors 24.
Figure 14: Chiral 15-crown-5 receptors 26 and an analogue 18-crown-6 ligand 27 derived from amino alcohols.
Figure 15: C2-symmetric chiral 18-crown-6 amino alcohol derivatives 28 and related macrocycles.
Figure 16: Macrocycles with diamide-diester groups (30).
Figure 17: C2-symmetric chiral aza-18-crown-6 ethers (31) with phenethylamine residues.
Figure 18: Chiral C-pivot p-methoxy-phenoxy-lariat ethers.
Figure 19: Chiral lariat crown ether 34.
Figure 20: Sucrose-based chiral crown ether receptors 36.
Figure 21: Permethylated fructooligosaccharide 37 showing induced-fit chiral recognition.
Figure 22: Biphenanthryl-18-crown-6 derivative 38.
Figure 23: Chiral lariat crown ethers derived from binol by Fuji et al.
Figure 24: Chiral phenolic crown ether 41 with “aryl chiral barriers” and guest amines.
Figure 25: Chiral bis-crown receptor 43 with a meso-ternaphthalene backbone.
Figure 26: Chromogenic pH-dependent bis-crown chemosensor 44 for diamines.
Figure 27: Triamine guests for binding to receptor 44.
Figure 28: Chiral bis-crown phenolphthalein chemosensors 46.
Figure 29: Crown ether amino acid 47.
Figure 30: Luminescent receptor 48 for bis-alkylammonium guests.
Figure 31: Luminescent CEAA (49a), a bis-CEAA receptor for amino acids (49b) and the structure of lysine bindi...
Figure 32: Luminescent CEAA tripeptide for binding small peptides.
Figure 33: Bis crown ether 51a self assembles co-operatively with C60-ammonium ion 51b.
Figure 34: Triptycene-based macrotricyclic dibenzo-[24]-crown-8 ether host 52 and guests.
Figure 35: Copper imido diacetic acid azacrown receptor 53a and the suggested His-Lys binding motif; a copper ...
Figure 36: Urea (54) and thiourea (55) benzo crown receptor for transport and extraction of amino acids.
Figure 37: Crown pyryliums ion receptors 56 for amino acids.
Figure 38: Ditopic sulfonamide bridged crown ether receptor 57.
Figure 39: Luminescent peptide receptor 58.
Figure 40: Luminescent receptor 59 for the detection of D-glucosamine hydrochloride in water/ethanol and lumin...
Figure 41: Guanidinium azacrown receptor 61 for simple amino acids and ditopic receptor 62 with crown ether an...
Figure 42: Chiral bicyclic guanidinium azacrown receptor 63 and similar receptor 64 for the enantioselective t...
Figure 43: Receptors for zwitterionic species based on luminescent CEAAs.
Figure 44: 1,10-Azacrown ethers with sugar podand arms and the anticancer agent busulfan.
Figure 45: Benzo-18-crown-6 modified β-cyclodextrin 69 and β-cyclodextrin functionalized with diaza-18-crown-6...
Figure 46: Receptors for colorimetric detection of primary and secondary ammonium ions.
Figure 47: Porphyrine-crown-receptors 72.
Figure 48: Porphyrin-crown ether conjugate 73 and fullerene-ammonium ion guest 74.
Figure 49: Calix[4]arene (75a), homooxocalix[4]arene (75b) and resorcin[4]arene (75c) compared (R = H, alkyl c...
Figure 50: Calix[4]arene and ammonium ion guest (R = H, alkyl, OAcyl etc.), possible binding sites; A: co-ordi...
Figure 51: Typical guests for studies with calixarenes and related molecules.
Figure 52: Lower rim modified p-tert-butylcalix[5]arenes 82.
Figure 53: The first example of a water soluble calixarene.
Figure 54: Sulfonated water soluble calix[n]arenes that bind ammonium ions.
Figure 55: Displacement assay for acetylcholine (3) with a sulfonato-calix[6]arene (84b).
Figure 56: Amino acid inclusion in p-sulfonatocalix[4]arene (84a).
Figure 57: Calixarene receptor family 86 with upper and lower rim functionalization.
Figure 58: Calix[6]arenes 87 with one carboxylic acid functionality.
Figure 59: Sulfonated calix[n]arenes with mono-substitution at the lower rim systematically studied on their r...
Figure 60: Cyclotetrachromotropylene host (91) and its binding to lysine (81c).
Figure 61: Calixarenes 92 and 93 with phosphonic acids groups.
Figure 62: Calix[4]arene tetraphosphonic acid (94a) and a double bridged analogue (94b).
Figure 63: Calix[4]arene tetraphosphonic acid ester (92c) for surface recognition experiments.
Figure 64: Calixarene receptors 95 with α-aminophosphonate groups.
Figure 65: A bridged homocalix[3]arene 95 and a distally bridged homocalix[4]crown 96.
Figure 66: Homocalix[3]arene ammonium ion receptor 97a and the Reichardt’s dye (97b) for colorimetric assays.
Figure 67: Chromogenic diazo-bridged calix[4]arene 98.
Figure 68: Calixarene receptor 99 by Huang et al.
Figure 69: Calixarenes 100 reported by Parisi et al.
Figure 70: Guest molecules for inclusion in calixarenes 100: DAP × 2 HCl (101a), APA (101b) and Lys-OMe × 2 HC...
Figure 71: Different N-linked peptido-calixarenes open and with glycol chain bridges.
Figure 72: (S)-1,1′-Bi-2-naphthol calixarene derivative 104 published by Kubo et al.
Figure 73: A chiral ammonium-ion receptor 105 based on the calix[4]arene skeleton.
Figure 74: R-/S-phenylalaninol functionalized calix[6]arenes 106a and 106b.
Figure 75: Capped homocalix[3]arene ammonium ion receptor 107.
Figure 76: Two C3 symmetric capped calix[6]arenes 108 and 109.
Figure 77: Phosphorous-containing rigidified calix[6]arene 110.
Figure 78: Calix[6]azacryptand 111.
Figure 79: Further substituted calix[6]azacryptands 112.
Figure 80: Resorcin[4]arene (75c) and the cavitands (113).
Figure 81: Tetrasulfonatomethylcalix[4]resorcinarene (114).
Figure 82: Resorcin[4]arenes (115a/b) and pyrogallo[4]arenes (115c, 116).
Figure 83: Displacement assay for acetylcholine (3) with tetracyanoresorcin[4]arene (117).
Figure 84: Tetramethoxy resorcinarene mono-crown-5 (118).
Figure 85: Components of a resorcinarene based displacement assay for ammonium ions.
Figure 86: Chiral basket resorcin[4]arenas 121.
Figure 87: Resorcinarenes with deeper cavitand structure (122).
Figure 88: Resorcinarene with partially open deeper cavitand structure (123).
Figure 89: Water-stabilized deep cavitands with partially structure (124, 125).
Figure 90: Charged cavitands 126 for tetralkylammonium ions.
Figure 91: Ditopic calix[4]arene receptor 127 capped with glycol chains.
Figure 92: A calix[5]arene dimer for diammonium salt recognition.
Figure 93: Calixarene parts 92c and 129 for the formation molecular capsules.
Figure 94: Encapsulation of a quaternary ammonium cation by two resorcin[4]arene molecules (NMe4+@[75c]2 × Cl−...
Figure 95: Encapsulation of a quaternary ammonium cation by six resorcin[4]arene molecules (NMe3D+@[130]6 × Cl−...
Figure 96: Structure and schematic of cucurbit[6]uril (CB[6], 131a).
Figure 97: Cyclohexanocucurbit[6]uril (CB′[6], 132) and the guest molecule spermine (133).
Figure 98: α,α,δ,δ-Tetramethylcucurbit[6]uril (134).
Figure 99: Structure of the cucurbituril-phthalhydrazide analogue 135.
Figure 100: Organic cavities for the displacement assay for amine differentiation.
Figure 101: Displacement assay methodology for diammonium- and related guests involving cucurbiturils and some ...
Figure 102: Nor-seco-Cucurbituril (±)-bis-ns-CB[6] (140) and guest molecules.
Figure 103: The cucurbit[6]uril based complexes 141 for chiral discrimination.
Figure 104: Cucurbit[7]uril (131c) and its ferrocene guests (142) opposed.
Figure 105: Cucurbit[7]uril (131c) guest inclusion and representative guests.
Figure 106: Cucurbit[7]uril (131c) binding to succinylcholine (145) and different bis-ammonium and bis-phosphon...
Figure 107: Paraquat-cucurbit[8]uril complex 149.
Figure 108: Gluconuril-based ammonium receptors 150.
Figure 109: Examples of clefts (151a), tweezers (151b, 151c, 151d) and clips (151e).
Figure 110: Kemp’s triacid (152a), on example of Rebek’s receptors (152b) and guests.
Figure 111: Amino acid receptor (154) by Rebek et al.
Figure 112: Hexagonal lattice designed hosts by Bell et al.
Figure 113: Bell’s amidinium receptor (156) and the amidinium ion (157).
Figure 114: Aromatic phosphonic acids.
Figure 115: Xylene phosphonates 159 and 160a/b for recognition of amines and amino alcohols.
Figure 116: Bisphosphonate recognition motif 161 for a colorimetric assay with alizarin complexone (163) for ca...
Figure 117: Bisphosphonate/phosphate clip 164 and bisphosphonate cleft 165.
Figure 118: N-Methylpyrazine 166a, N-methylnicotinamide iodide (166b) and NAD+ (166c).
Figure 119: Bisphosphate cavitands.
Figure 120: Bisphosphonate 167 of Schrader and Finocchiaro.
Figure 121: Tweezer 168 for noradrenaline (80b).
Figure 122: Different tripods and heparin (170).
Figure 123: Squaramide based receptors 172.
Figure 124: Cage like NH4+ receptor 173 of Kim et al.
Figure 125: Ammonium receptors 174 of Chin et al.
Figure 126: 2-Oxazolin-based ammonium receptors 175a–d and 176 by Ahn et al.
Figure 127: Racemic guest molecules 177.
Figure 128: Tripods based on a imidazole containing macrocycle (178) and the guest molecules employed in the st...
Figure 129: Ammonium ion receptor 180.
Figure 130: Tetraoxa[3.3.3.3]paracyclophanes 181 and a cyclophanic tetraester (182).
Figure 131: Peptidic bridged paraquat-cyclophane.
Figure 132: Shape-selective noradrenaline host.
Figure 133: Receptor 185 for binding of noradrenaline on surface layers from Schrader et al.
Figure 134: Tetraphosphonate receptor for binding of noradrenaline.
Figure 135: Tetraphosphonate 187 of Schrader and Finocchiaro.
Figure 136: Zinc-Porphyrin ammonium-ion receptors 188 and 189 of Mizutani et al.
Figure 137: Zinc porphyrin receptor 190.
Figure 138: Zinc porphyrin receptors 191 capable of amino acid binding.
Figure 139: Zinc-porphyrins with amino acid side chains for stereoinduction.
Figure 140: Bis-zinc-bis-porphyrin based on Tröger’s base 193.
Figure 141: BINAP-zinc-prophyrin derivative 194 and it’s guests.
Figure 142: Bisaryl-linked-zinc-porphyrin receptors.
Figure 143: Bis-zinc-porphyrin 199 for diamine recognition and guests.
Figure 144: Bis-zinc-porphyrin crown ether 201.
Figure 145: Bis-zinc-porphyrin 202 for stereodiscrimination (L = large substituent; S = small substituent).
Figure 146: Bis-zinc-porphyrin[3]rotaxane and its copper complex and guests.
Figure 147: Dien-bipyridyl ligand 206 for co-ordination of two metal atoms.
Figure 148: The ligand and corresponding tetradentate co-complex 207 serving as enantioselective receptor for a...
Figure 149: Bis(oxazoline)–copper(II) complex 208 for the recognition of amino acids in aqueous solution.
Figure 150: Zinc-salen-complexes 209 for the recognition tertiary amines.
Figure 151: Bis(oxazoline)–copper(II) 211 for the recognition of amino acids in aqueous solution.
Figure 152: Zn(II)-complex of a C2 terpyridine crown ether.
Figure 153: Displacement assay and receptor for aspartate over glutamate.
Figure 154: Chiral complex 214 for a colorimetric displacement assay for amino acids.
Figure 155: Metal complex receptor 215 with tripeptide side arms.
Figure 156: A sandwich complex 216 and its displaceable dye 217.
Figure 157: Lanthanide complexes 218–220 for amino acid recognition.
Figure 158: Nonactin (221), valinomycin (222) and vancomycin (223).
Figure 159: Monesin (224a) and a chiral analogue for enantiodiscrimination of ammonium guests (224b).
Figure 160: Chiral podands (226) compared to pentaglyme-dimethylether (225) and 18-crown-6 (4).
Figure 161: Lasalocid A (228).
Figure 162: Lasalocid derivatives (230) of Sessler et al.
Figure 163: The Coporphyrin I tetraanion (231).
Figure 164: Linear and cyclic peptides for ammonium ion recognition.
Figure 165: Cyclic and bicyclic depsipeptides for ammonium ion recognition.
Figure 166: α-Cyclodextrin (136a) and novocaine (236).
Figure 167: Helical diol receptor 237 by Reetz and Sostmann.
Figure 168: Ammonium binding spherand by Cram et al. (238a) and the cyclic[6]metaphenylacetylene 238b in compar...
Figure 169: Receptor for peptide backbone and ammonium binding (239).
Figure 170: Anion sensor principle with 3-hydroxy-2-naphthanilide of Jiang et al.
Figure 171: 7-bromo-3-hydroxy-N-(2-hydroxyphenyl)naphthalene 2-carboxamide (241) and its amine binding.
Figure 172: Naturally occurring catechins with affinity to quaternary ammonium ions.
Figure 173: Spiropyran (244) and merocyanine form (244a) of the amino acid receptors of Fuji et al.
Figure 174: Coumarin aldehyde (245) and its iminium species with amino acid bound (245a) by Glass et al.
Figure 175: Coumarin aldehyde appended with boronic acid.
Figure 176: Quinolone aldehyde dimers by Glass et al.
Figure 177: Chromogenic ammonium ion receptors with trifluoroacetophenone recognition motifs.
Figure 178: Chromogenic ammonium ion receptor with trifluoroacetophenone recognition motif bound on different m...
Beilstein J. Org. Chem. 2010, 6, No. 5, doi:10.3762/bjoc.6.5
Graphical Abstract
Figure 1: Schematic representation of the design of a host–guest complex based on antiparallel β-sheet geomet...
Figure 2: Molecular structures of the two designed receptors 1 and 2 having different relative orientations o...
Figure 3: CAChe minimized structures for the “endo” complexes formed between receptors 1 (a) and 2 (b) and th...
Scheme 1: Synthesis of tetraprotected bis(alanyl)benzophenones 3 from L-phenylalanine 7.
Scheme 2: Deprotection reactions of bis(alanyl)benzophenone units 3.
Scheme 3: Synthesis of the linear tetrapeptides 15 and 17 as mixtures of diastereoisomers.
Figure 4: a) Molecular structures of the two major diastereoisomers of the cyclic receptors obtained from the...
Figure 5: Reverse-phase HPLC chromatograms of the purified fraction obtained from macrocyclization reactions ...
Figure 6: Variable-temperature 1H NMR experiments of 1 in chloroform-d solution. The proton signals that appe...
Figure 7: Small fraction of the columnar arrangement observed in solid-state packing of receptor 1. Two adjac...
Figure 8: Molecular structures of the guests used in the binding experiments.
Figure 9: Selected region of the variable-concentration 1H NMR spectra acquired using chloroform-d solutions ...
Figure 10: a) Selected region of a series 1H NMR spectra acquired during titration of receptor 2 with n-C6H13-...
Figure 11: CAChe minimized structures for two possible binding geometries, a) exo and b) endo complexes formed...
Beilstein J. Org. Chem. 2009, 5, No. 33, doi:10.3762/bjoc.5.33
Graphical Abstract
Scheme 1: Aziridine containing natural products.
Scheme 2: Mitomycin structures and nomenclature.
Scheme 3: Base catalysed epimerization of mitomycin B.
Scheme 4: Biosynthesis of mitomycin C (MMC) 7.
Scheme 5: Mode of action of mitomycin C.
Scheme 6: The N–C3–C9a disconnection.
Scheme 7: Danishefsky’s Retrosynthesis of mitomycin K.
Scheme 8: Hetero Diels–Alder reaction en route to mitomycins.
Scheme 9: Nitroso Diels–Alder cycloaddition.
Scheme 10: Frank azide cycloadddition.
Scheme 11: Final steps of mitomycin K synthesis. aPDC, DCM; bPhSCH2N3, PhH, 80 °C; cL-selectride, THF, −78 °C; ...
Scheme 12: Naruta–Maruyama retrosynthesis.
Scheme 13: Synthesis of a leucoaziridinomitosane by nitrene cycloaddition. aAlCl3-Et2O; bNaH, ClCH2OMe; cn-BuL...
Scheme 14: Thermal decomposition of azidoquinone 51.
Scheme 15: Diastereoselectivity during the cycloaddition.
Scheme 16: Oxidation with iodo-azide.
Scheme 17: Williams’ approach towards mitomycins.aDEIPSCl, Imidazole, DCM; bPd/C, HCO2NH4, MeOH; cAllocCl, NaH...
Scheme 18: Synthesis of pyrrolidones by homoconjugate addition.
Scheme 19: Homoconjugate addition on the fully functionalized substrate.
Scheme 20: Introduction of the olefin.
Scheme 21: Retrosynthesis of N–C9a, N–C3 bond formation.
Scheme 22: Synthesis of the pyrrolo[1,2]indole 82 using N-PSP activation.aAc2O, Py; bAc2O, Hg(OAc)2, AcOH, 90%...
Scheme 23: Synthesis of an aziridinomitosane. am-CPBA, DCM then iPr2NH, CCl4 reflux; bK2CO3, MeOH; cBnBr, KH; d...
Scheme 24: Oxidation products of a leucoaziridinomitosane obtained from a Polonovski oxidation.
Scheme 25: Polonovski oxidation of an aziridinomitosane. am-CPBA; bPd/C, H2; cDimethoxypropane, PPTS.
Scheme 26: The C1–C9a disconnection.
Scheme 27: Ziegler synthesis of desmethoxymitomycin A.aIm2C=O, THF; bNH3; cTMSOTf, 2,6-di-tert-butylpyridine, ...
Scheme 28: Transformation of sodium erythorbate.aTBDMSCl; bNaN3; cPPh3; d(Boc)2O, DMAP; eTBAF; fTf2O, Pyr.
Scheme 29: Formation of C9,C10-unsaturation in the mitomycins. am-CPBA, DCM; bO3, MeOH; cMe2S; dKHMDS, (EtO)3P...
Scheme 30: Fragmentation mechanism.
Scheme 31: Michael addition-cyclisation.
Scheme 32: SmI2 8-endo-dig cyclisation.
Scheme 33: Synthesis of pyrrolo[1,2-a]indole by 5-exo-dig radical cyclization.
Scheme 34: The C9–C9a disconnection.
Scheme 35: Intramolecular nitrile oxide cycloaddition.
Scheme 36: Regioselectivity of the INOC.
Scheme 37: Fukuyama’s INOC strategy.
Scheme 38: Synthesis of a mitosane core by rearrangement of a 1-(1-pyrrolidinyl)-1,3-butadiene.
Scheme 39: Sulikowski synthesis of an aziridinomitosene. aPd(Tol3P)2Cl2, Bu3SnF, 140; bH2, Pd/C; cTFAA, Et3N; d...
Scheme 40: Enantioselective carbene insertion.
Scheme 41: Parson’s radical cyclization.
Scheme 42: Cha’s mitomycin B core synthesis.
Scheme 43: The N-aromatic disconnection.
Scheme 44: Kishi retrosynthesis.
Scheme 45: Kishi synthesis of a starting material. aallyl bromide, K2CO3, acetone, reflux; bN,N-Dimethylanilin...
Scheme 46: Kishi synthesis of MMC 7. aLDA, THF, −78 °C then PhSeBr, THF, −78 °C; bH2O2, THF-EtOAc; cDIBAL, DCM...
Scheme 47: Acid catalyzed degradation of MMC 7.
Scheme 48: In vivo formation of apomitomycin B.
Scheme 49: Advanced intermediate for apomitomycin B synthesis.
Scheme 50: Remers synthesis of a functionalized mitosene. aTMSCl, Et3N, ZnCl2 then NBS; bAcOK; cNH2OH; dPd/C, H...
Scheme 51: Coleman synthesis of desmethoxymitomycin A. aSnCl2, PhSH, Et3N, CH3CN; bClCO2Bn, Et3N; cPPh3, DIAD,...
Scheme 52: Transition state and pyrrolidine synthesis.
Scheme 53: Air oxidation of mitosanes and aziridinomitosanes.
Scheme 54: The C9-aromatic disconnection.
Scheme 55: Synthesis of the aziridine precursor. aLHMDS, THF; bNaOH; c(s)-α-Me-BnNH2, DCC, HOBT; dDIBAL; eK2CO3...
Scheme 56: Synthesis of 206 via enamine conjugate addition.
Scheme 57: Rapoport synthesis of an aziridinomitosene.
Scheme 58: One pot synthesis of a mitomycin analog.
Scheme 59: Synthesis of compound 218 via intramolecular Heck coupling. aEtMgCl, THF, then 220; bMsCl, Et3N; cN...
Scheme 60: Elaboration of indole 223. aEt3N, Ac2O; bAcOH; cSOCl2, Et3N; dNaN3, DMF; eH2SO4, THF; fK2CO3, MeOH; ...
Scheme 61: C9-C9a functionalization from indole.
Scheme 62: Synthesis of mitomycin K. a2 equiv. MoO5.HMPA, MeOH; bPPh3, Et3N, THF-H2O; cMeOTf, Py, DCM; dMe3SiCH...
Scheme 63: Configurational stability of mitomycin K derivatives.
Scheme 64: Epimerization of carbon C9a in compound 227b.
Scheme 65: Corey–Chaykovsky synthesis of indol 235.
Scheme 66: Cory intramolecular aza-Darzens reaction for the formation of aziridinomitosene 239.
Scheme 67: Jimenez synthesis of aziridinomitosene 242.
Scheme 68: Von Braun opening of indoline 244.
Scheme 69: C9a oxidation of an aziridinomitosane with DDQ/OsO4.
Scheme 70: Synthesis of epi-mitomycin K. aNaH, Me2SO4; bH2, Pd/C; cMitscher reagent [165]; d[(trimethylsilyl)methyl...
Scheme 71: Mitomycins rearrangement.
Scheme 72: Fukuyama’s retrosynthesis.
Scheme 73: [2+3] Cycloaddition en route to isomitomycin A. aToluene, 110 °C; bDIBAL, THF, −78 °C; cAc2O, Py.; d...
Scheme 74: Final steps of Fukuyama’s synthesis.
Scheme 75: “Crisscross annulation”.
Scheme 76: Synthesis of 274; the 8-membered ring 274 was made using a crisscross annulation. a20% Pd(OH)2/C, H2...
Scheme 77: Conformational analysis of compound 273 and 275.
Scheme 78: Synthesis of a mitomycin analog. aNa2S2O4, H2O, DCM; bBnBr (10 equiv), K2CO3, 18-crown-6 (cat.), TH...
Scheme 79: Vedejs retrosynthesis.
Scheme 80: Formation of the azomethine ylide.
Scheme 81: Vedejs second synthesis of an aziridinomitosene. aDIBAL; bTPAP, NMO; c287; dTBSCl, imidazole.
Scheme 82: Trityl deprotection and new aziridine protecting group 300.
Scheme 83: Ene reaction towards benzazocinones.
Scheme 84: Benzazocenols via homo-Brook rearrangement.
Scheme 85: Pt-catalyzed [3+2] cycloaddition.
Scheme 86: Carbonylative lactamization entry to benzazocenols. aZn(OTf)2, (+)-N-methylephedrine, Et3N, TMS-ace...
Scheme 87: 8 membered ring formation by RCM. aBOC2O, NaHCO3; bTBSCl, Imidazole, DMF; callyl bromide, NaH, DMF; ...
Scheme 88: Aziridinomitosene synthesis. aTMSN3; bTFA; cPOCl3, DMF; dNaClO2, NaH2PO4, 2-methyl-2-butene; eMeI, ...
Scheme 89: Metathesis from an indole.
Scheme 90: Synthesis of early biosynthetic intermediates of mitomycins.
Beilstein J. Org. Chem. 2006, 2, No. 19, doi:10.1186/1860-5397-2-19
Graphical Abstract
Scheme 1: Synthesis of vicinal dimethyl difluorosuccinates. The conversion of the tartrates 1 with SF4 and HF ...
Scheme 2: Schlosser's route to vicinal erythro- or threo- difluoro alkanes 5 [13].
Scheme 3: Halofluorination of electron-rich alkenes with in situ fluoride displacement generates vicinal difl...
Scheme 4: Bromofluorination of stilbene [19].
Scheme 5: Treatment of anti-14 with base generated the E-fluorostilbene 15 by an anti elimination mechanism.
Scheme 6: Hypothesis for the predominent retention of configuration during fluoride substitution via phenoniu...
Scheme 7: Proposed C-C bond rotation during the preparation of 14 from cis-stilbene.
Figure 1: Crystal structure of erythro-13.
Figure 2: X-ray structure of threo-13.
Figure 3: Expanded regions of the second order AA'XX' spin systems in the 1H-NMR (left) and 19F-NMR spectra (...
Figure 4: NMR coupling constants and calculated relative energies (kcalmol-1) of the staggered conformers of ...
Scheme 8: Synthesis of erythro-19 via ozonolysis of erythro-13.
Figure 5: X-ray structure of erythro-19.
Figure 6: X-ray structure of threo-19.
Scheme 9: Strategy for the preparation of diastereoisomers of erythro- and threo- 20.
Figure 7: NMR (CDCl3, RT) coupling constants of erythro- and threo- 2,3-difluoro-3-phenylpropionates 21.
Figure 8: Newman projections showing the staggered conformations of erythro- and threo- 21.
Figure 9: X-ray structure of methyl threo- 21.
Figure 10: The preferred conformation of α-fluoroamides has the C-F and amide carbonyl anti-planar [29,30].
Scheme 10: The synthesis of stereoisomers of erythro- and threo- 22. These isomers could be separated by chrom...
Figure 11: X-ray structure of erythro-22.
Figure 12: Crystal packing of erythro-22 clearly indicating intermolecular hydrogen bonding.
Figure 13: X-ray structure of threo-22.
Figure 14: The conformations of erythro- and threo- 23 are very different as a consequence of each conformatio...
Figure 15: 3JHF and 3JHH coupling constants for the erythro (yellow) and threo (blue) diastereoisomers of the ...
Figure 16: Newman projections of the three staggered conformations of the erythro and threo stereoisomers of t...
Figure 17: The average coupling constant with no conformational bias. The limiting coupling constants Jg = 8 H...
Figure 18: The observed 3JHF coupling constants are an average over the rotational isomers.